BUSPIRONE IS EFFECTIVE ON CENTRAL APNEAS IN PATIENTS WITH SYSTOLIC HEART FAILURE

The current therapeutic approach for central apneas (CA) in heart failure (HF) with non-invasive mechanical ventilation -that targets “sleep apneas”- has a negative prognostic impact and does not affect CA pathophysiological triggers or daytime CA. We hypothesized that buspirone, a 5HT1a